High Expression of NLRC5 is associated with prognosis of gastric cancer
To explore the relationships of NLRC5 with clinicopathological characteristics and prognosis of gastric cancer patients.
Main Authors: | Li Yuemei, Zhang Min, Zheng Xinhua |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2018-10-01
|
Series: | Open Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1515/med-2018-0066 |
Similar Items
-
Clinical and Molecular Correlates of NLRC5 Expression in Patients With Melanoma
by: Lei Lv, et al.
Published: (2021-07-01) -
Clinicopathological Characteristics and Prognosis of Borrmann Type Ⅳ Gastric Cancer
by: DING Pingan, et al.
Published: (2021-03-01) -
EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance
by: Wenjing Gong, et al.
Published: (2021-04-01) -
Prognostic value of differentiation status in gastric cancer
by: Fan Feng, et al.
Published: (2018-09-01) -
The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy
by: Akhil Shukla, et al.
Published: (2021-02-01)